Regulatory action, trial pauses and renewed cancer drug approvals

October 29, 2025

1. Texas sues Tylenol makers, alleging drug's links to autism Full story

2. FDA approves cancer drug previously pulled from market Full story

3. Stop chasing short-term fixes. See 1 system's ROI-driven OR overhaul: here.

4. Senators push FDA for stricter oversight of foreign drugmakers Full story

5. GLP-1 prescription rate relatively flat: Study Full story

 

6. Inova unlocked 20% more OR minutes — no new rooms needed. See how here.

7. FDA approves non-hormonal drug for menopause Full story

8. Intellia halts 2 gene therapy trials after patient hospitalized Full story

Becker's Learning Opportunities

9. Star ratings up, heart care costs down: This on-demand session explains how here.

10. Pressure injuries cost $22K per patient. What hospitals can do about it here.

11. MUSC Health avoided 14,500 no-shows with AI. Its strategy: here.

12. Becker’s resources don’t stop here — explore more webinars and whitepapers.

 

Companies to Know
Thank you to our key sponsors


LeanTaaS | Abridge | Philips | Vituity | ECG Management Consultants | CorroHealth | symplr | AMN Healthcare | Ambience Healthcare | Intuitive  

 

 
 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication